|
Mr. Wilcox is a Partner and Chief Financial Officer of Flagship Ventures. His career spans 28 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has served on several Boards of Directors. In addition to his corporate experience, Mr. Wilcox was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures. Most recently, he served as CFO and Sr. VP Corporate Development for EXACT Sciences. In addition to his role at EXACT Sciences, Mr. Wilcox led an active consulting practice which included roles as interim CEO of two biotech companies: Thrasos Therapeutics and Biostratum. Prior to this, Mr. Wilcox was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held biotech company. Earlier, he had been the President and Chief Executive Officer of Cambridge NeuroScience, Inc. until its sale to CeNeS Pharmaceuticals, and before that Sr. VP Business Development and CFO of Cellcor. | 